Arcadia Biosciences Inc

NASDAQ RKDA

Data sourced from iex and EODHD
Download Data

Arcadia Biosciences Inc Cash Flow Statement 2012 - 2023

This table shows the Cash Flow Statement for Arcadia Biosciences Inc going from 2012 until 2023. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31
Net Income
M -13 -16 -16 -6 -29 -13 -16 -20 -18 -18 -13 -12
Depreciation and Amortization
M 1 0 1 1 0 0 0 0 0 0 0 0
Non-Cash Items (Other)
M 0 -1 0 -15 0 3 0 0 1 1 0 2
Operating Cash Flow
M -15 -14 -26 -30 -17 -14 -14 -17 -15 -15 -10 -10
Capital Expenditures
M 0 0 -1 -2 -1 0 0 0 0 0 0 0
Net Acquisitions
M - - - - - - - - - - - -
Other Investing Activities
M - - - 0 0 0 0 -5 0 0 - -
Investing Cash Flow
M - - - 0 0 0 0 -5 0 0 - -
Repayment/Issuance of Debt (Net)
M - - -2 3 0 0 -26 0 35 -1 - -
Equity Repurchase (Common, Net)
M - - 25 9 5 10 0 0 46 0 - -
Dividends Paid
M - - - - - - 0 0 0 - - -
Other Financial Activities
M 6 0 24 13 4 -12 0 0 -10 31 9 8
Financing Cash Flow
M 6 0 24 13 4 -12 0 0 -10 31 9 8
Exchange Rate Adjustment
M - - - - - - - - - - - -
Beginning Cash
M 21 29 16 8 12 9 2 24 17 3 5 7
Ending Cash
M 7 21 29 16 8 12 9 2 24 17 3 5
Stock-Based Compensation
M 1 1 2 2 2 2 1 1 1 1 1 1
Issuance/Purchase of Shares
M - - 25 9 5 10 0 0 46 0 - -
Capital Stock Change
M 6 5 25 8 18 24 - - - - - -
Working Capital
M 11 21 30 25 23 20 12 49 49 7 -5 5
Free Cash Flow
M -15 -14 -27 -33 -19 -14 -14 -17 -15 -15 -10 -10

StockViz Staff

September 19, 2024

Any question? Send us an email